Medical device and MedTech insights, news, tips and more

Former Stryker Engineer Pleads Guilty to Accepting Bribe

May 1, 2018

2sy82pvn-1452540111

Daniel Lawrynowicz, a former Stryker Corporation engineering director, pled guilty on April 3, 2018 to accepting a $75,000 bribe for steering business to a New York metallurgy firm.

According to the Department of Justice (DoJ), Lawrynowicz, 48, pleaded guilty before U.S. District Judge Madeline Cox Arleo in Newark federal court to an information charging him with one count of violating the Federal Travel Act.

According to DOJ documents, in 2012, while Lawrynowicz was an employee of Stryker, Eugene Ostrovsky and two other individuals at Sanova LLC, sought a contract worth $5.5 million with Stryker. Lawrynowicz was in a position to make recommendations to others at Stryker related to the goods that Sanova sought to supply under the contract.

“Ostrovsky and the other individuals made illicit bribe payments to Lawrynowicz in exchange for his assistance in helping the technology company secure the contract with the medical device company. These payments included a cash payment of approximately $75,000 to Lawrynowicz after the contract between the two companies was signed.”

Sanova VP Pleads Guilty

In February, Ostrovsky, a vice president and partner at Sanova LLC, pleaded guilty to bribing Lawrynowicz in 2012 and 2013 to win the $5.5 million contract with Stryker. He was sentenced March 9 to six months in jail, six months of home confinement and two years of supervised release. Prosecutors said Ostrovsky will also forfeit $1.1 million.

Lawrynowicz’s LinkedIn page listed him as a 15-year Stryker employee who was senior director of advanced engineering, leading “a team of 41 engineers and scientists at the Mahwah, N.J. facility dedicated to supporting the Recon Business Units.”

Read More at the Source: Former Stryker Engineer Pleads Guilty to Accepting Bribe | Orthopedics This Week


By: Walter Eisner

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.